查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1233635

全球陰道抗真菌藥市場：克黴唑約佔三分之一市場份額

Market Study on Vaginal Antifungals: Around One-third Market Share Accounted for by Clotrimazole Drugs
出版日期: | 出版商: Persistence Market Research | 英文 250 Pages | 商品交期: 2-5個工作天內

價格

本報告研究和分析了全球陰道抗真菌藥市場，提供了系統的信息，包括市場概況、趨勢、機會、按細分市場和地區劃分的市場分析、競爭格局和公司概況。我來了。

內容

第 1 章執行摘要

第 2 章市場概述

  • 市場範圍/分類
  • 市場定義/範圍/限制
  • 包含和排除

第 3 章主要市場趨勢

  • 影響市場的主要趨勢
  • 主要創新/發展趨勢

第 4 章關鍵成功因素

  • 促銷策略：按主要製造商
  • 主要規定
  • 贖回場景
  • 管道分析
  • 價值鏈分析
  • PESTEL 分析
  • 波特的分析

第五章市場背景

  • 宏觀經濟因素
  • 預測因素：相關性和影響
  • 市場動態

第 6 章 COVID-19 危機分析

  • COVID-19 和影響分析
    • 通過藥物
    • 按給藥途徑
    • 按分銷渠道
    • 按國家
  • 2021 年市場情景

第七章全球陰道抗真菌藥市場需求分析及預測

  • 過去的市場分析
  • 當前和未來的市場預測
    • 同比增長率趨勢分析

第 8 章全球陰道抗真菌藥物市場分析和預測：按藥物分類

  • 簡介/主要發現
  • 過去的市場分析：按藥物
  • 當前和未來的市場分析和預測：按藥物分類
    • 氟康唑
    • 制黴菌素
    • 果胞嘧啶
    • 克黴唑
    • 酮康唑
    • 特比□芬
    • 其他
  • 市場吸引力分析：按藥物

第 9 章全球陰道抗真菌藥市場分析和預測：按給藥途徑

  • 簡介/主要發現
  • 過去的市場分析：按給藥途徑
  • 當前和未來的市場分析和預測：按給藥途徑
    • 口語
    • 本地
  • 市場吸引力分析：按給藥途徑

第 10 章全球陰道抗真菌藥市場分析和預測：按分銷渠道

  • 簡介/主要發現
  • 過去的市場分析：按分銷渠道
  • 當前和未來的市場分析和預測：按分銷渠道
    • 醫院藥房
    • 零售藥房
    • 在線藥店
  • 市場吸引力分析：按分銷渠道

第 11 章全球陰道抗真菌藥市場分析和預測：按地區

  • 簡介/主要發現
  • 過去的市場分析：按地區
  • 當前和未來的市場分析和預測：按地區
    • 北美
    • 拉丁美洲
    • 歐洲
    • 東亞
    • 南亞
    • 大洋洲
    • 中東和非洲
  • 市場吸引力分析：按地區

第12章北美陰道抗真菌藥市場分析及預測

  • 介紹
  • 分析過去的市場趨勢：按市場分類
  • 當前和未來的市場分析和預測：按市場分類
    • 按國家
    • 通過藥物
    • 按給藥途徑
    • 按分銷渠道
  • 市場吸引力分析
    • 按國家
    • 通過藥物
    • 按給藥途徑
    • 按分銷渠道
  • 市場趨勢
  • 主要市場參與者：強度映射
  • 驅動因素和製約因素：影響分析
  • 國家層面的分析和預測
    • 美國
    • 加拿大

第 13 章拉丁美洲陰道抗真菌藥市場分析和預測

第14章歐洲陰道抗真菌藥市場分析及預測

第十五章東亞陰道抗真菌藥市場分析及預測

第 16 章南亞陰道抗真菌藥市場分析與預測

第十七章大洋洲陰道抗真菌藥市場分析及預測

第 18 章中東和非洲 (MEA) 陰道抗真菌市場分析和預測

第十九章市場結構分析

  • 市場分析：公司分類
  • 市場集中度
  • 主要公司的市場份額分析
  • 市場佔有率分析

第20章競爭分析

  • 比賽儀表板
  • 競爭基準
  • 衝突詳情
    • Pfizer Inc.
    • Bausch Health Companies Inc
    • ANI Pharmaceuticals, Inc.
    • Hikma Pharmaceuticals Plc
    • Lupin Limited
    • Mycovia Pharmaceuticals, Inc.
    • Glenmark Pharmaceuticals Limited
    • Unique Pharmaceuticals
    • PEPTONIC medical AB
    • Aurobindo Pharma Limited
    • Dr. Reddy's Laboratories
    • SCYNEXIS, Inc.
    • Basilea Pharmaceutica Ltd.
    • Astellas Pharma Inc.
    • Grupo Ferrer Internacional, S.A.
    • Pacgen Life Science Corporation
    • NovaDigm Therapeutics, Inc.
    • Cidara Therapeutics, Inc.
    • Amplyx Pharmaceuticals Inc.

第 21 章先決條件和使用的首字母縮略詞

第 22 章研究方法

Product Code: PMRREP33292

Vaginal Antifungals Market - Report Scope

A recent market study published by Persistence Market Research on the vaginal antifungals market offers a global industry analysis for 2017 to 2021 and an opportunity assessment for 2022 to 2032. The report consists of a comprehensive assessment of the most important market dynamics. On conducting thorough research on the historical as well as current growth parameters of the vaginal antifungals market, growth prospects of the market are obtained with maximum precision.

The report features unique and salient factors that may make a huge impact on the development of the vaginal antifungals market during the forecast period. It can help market players modify their manufacturing and marketing strategies to envisage maximum growth in this market in the coming years.

The report provides detailed information about the current and future growth prospects of the vaginal antifungals market in the most comprehensive way for a better understanding of readers.

Key Market Segments

The study on the vaginal antifungals market offers insights divided into four important segments - drug, route of administration, distribution channel, and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.

Drug

Fluconazole

Nystatin

Flucytosine

Clotrimazole

Ketoconazole

Terbinafine

Others

Route of Administration

Oral

Topical

Distribution Channel

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

Region

North America

Latin America

Europe

South Asia

East Asia

Oceania

Middle East and Africa

Chapter 1 - Executive Summary

  • The report commences with the executive summary of the vaginal antifungals market report, which includes the summary of key findings and statistics of the market. It also includes the market value (US$ million) estimates of the leading segments of the vaginal antifungals market as well as the key trends influencing the market.

Chapter 2 - Market Overview

  • Readers can find detailed taxonomy and drug definition/scope /limitations and inclusions and exclusions of the vaginal antifungals market in this chapter, which helps the readers to understand basic information about the vaginal antifungals market.

Chapter 3 - Key Market Trends

  • This section highlights the key trends influencing the vaginal antifungals market, which will help readers in understanding the current trends and their impact on market growth.

Chapter 4 - Key Success Factors

  • This section highlights the market context impacting the vaginal antifungals market, which will help readers in understanding promotional strategies, by key manufacturers, key regulations, reimbursement scenario, pipeline analysis, value chain analysis, PESTEL analysis, and Porter's analysis, that are expected to create a positive impact on the growth of the vaginal antifungals market during the forecast period.

Chapter 5- Market Background

  • This chapter explains the key macroeconomic factors that are expected to influence the growth of the vaginal antifungals market during the forecast period. The chapter also highlights the major forecast factors that will shape market growth. Besides, it provides key dynamics of the vaginal antifungals market, which include the drivers, restraints, and opportunity analysis.

Chapter 6 - COVID-19 Crisis Analysis

  • This section provides the current and expected impact of COVID-19 on the vaginal antifungals market.

Chapter 7- Global Vaginal Antifungals Market Demand (in Value or Size in US$ Mn) Analysis 2017-2021 and Forecast, 2022-2032

  • This section explains the global market value or size analysis and forecasts for the vaginal antifungals market during the forecast period. Along with the historical market and opportunity analysis of the future. Readers can also find the absolute $ opportunity for the current year (2022), and an incremental $ opportunity for the forecast period (2022-2032).

Chapter 8- Global Vaginal Antifungals Market Analysis 2017-2021 and Forecast 2022-2032, by Drug

  • Based on the drug, the vaginal antifungals market is segmented into Fluconazole, Nystatin, Flucytosine, Clotrimazole, Ketoconazole, Terbinafine, and others. In this chapter, readers can find information about a detailed analysis of the market by different drugs available in the vaginal antifungals market and their growth over the forecast period.

Chapter 9- Global Vaginal Antifungals Market Analysis 2017-2021 and Forecast 2022-2032, By Route of Administration

  • Based on the route of administration, the vaginal antifungals market is segmented into oral, and topical. In this chapter, readers can find information about a detailed analysis of the market by various routes of administration available in the vaginal antifungals market and their growth over the forecast period.

Chapter 10- Global Vaginal Antifungals Market Analysis 2017-2021 and Forecast 2022-2032, By Distribution Channel

  • Based on the distribution channel, the vaginal antifungals market is segmented into retail pharmacies, hospital pharmacies, and online pharmacies. In this chapter, readers can find information about a detailed analysis of the market by distribution channels available in the vaginal antifungals market and their growth over the forecast period.

Chapter 11 - Global Vaginal Antifungals Market Analysis 2017-2021 and Forecast 2022-2032, by Region

  • This chapter explains how the vaginal antifungals market will grow across seven geographic regions, North America, Latin America, Europe, South Asia, East Asia, Oceania, and Middle East and Africa (MEA).

Chapter 12- North America Vaginal Antifungals Market Analysis 2017-2021 and Forecast 2022-2032

  • This chapter includes a detailed analysis of the growth of the North American vaginal antifungals market along with a country-wise assessment including the U.S. and Canada. Readers can also find key takeaways of this region, and market growth based on drug, distribution channel, route of administration, and country of the vaginal antifungals market in the North American region.

Chapter 13- Latin America Vaginal Antifungals Market Analysis 2017-2021 and Forecast 2022-2032

  • This chapter includes the growth prospects of the vaginal antifungals market in leading countries such as Brazil, Mexico, Argentina, and the rest of Latin America. Readers can find thorough information about the growth parameters based on drug, distribution channel, route of administration, and country in the Latin America vaginal antifungals market during 2022-2032.

Chapter 14- Europe Vaginal Antifungals Market Analysis 2017-2021 and Forecast 2022-2032

  • This chapter includes the growth prospects of the vaginal antifungals market based on the development of the new product, regulatory approvals, and country in several European countries such as the U.K., Germany, France, Italy, Spain, Russia, BENELUX, and the Rest of Europe are included in this chapter.

Chapter 15- East Asia Vaginal Antifungals Market Analysis 2017-2021 and Forecast 2022-2032

  • China, Japan, and South Korea are the prime subjects of assessment to obtain the growth prospects of the East Asia vaginal antifungals market. In addition, in this chapter, readers can find thorough information about the growth parameters of the East Asia vaginal antifungals market through 2032.

Chapter 16- South Asia Vaginal Antifungals Market Analysis 2017-2021 and Forecast 2022-2032

  • India, Thailand, Indonesia, Malaysia, and the rest of South Asia are the prime subjects of assessment to obtain the growth prospects of the vaginal antifungals market. In addition, in this chapter, readers can find thorough information about the growth parameters of the South Asia vaginal antifungals market growth over the forecast period.

Chapter 17- Oceania Vaginal Antifungals Market Analysis 2017-2021 and Forecast 2022-2032

  • This chapter consists of important parameters that have a huge impact on the growth of the vaginal antifungals market in Oceania, based on market segmentation, during the forecast period. The chapter also provides an overview of the drivers, restraints, and trends in the Oceania vaginal antifungals market.

Chapter 18- Middle East and Africa Vaginal Antifungals Market Analysis 2017-2021 and Forecast 2022-2032

  • This chapter provides information on how the vaginal antifungals market will grow in the major countries in the MEA region, such as GCC Countries, Turkiye, and the rest of MEA during 2022-2032.

Chapter 19- Market Structure Analysis

  • This chapter highlights the tier structure analysis, market concentration analysis and company share analysis along with sales footprint analysis of key players operating in the vaginal antifungals market.

Chapter 20- Competition Analysis

  • In this chapter, readers can find a comprehensive list of all the prominent stakeholders in the vaginal antifungals market including company overview, revenue shares, strategic overview, and recent company developments. Some of the major market players featured in the report are Pfizer Inc., Bausch Health Companies Inc, ANI Pharmaceuticals, Inc., Hikma Pharmaceuticals Plc, Lupin Limited, Mycovia Pharmaceuticals, Inc., Glenmark Pharmaceuticals Limited, Unique Pharmaceuticals, PEPTONIC Medical AB, Aurobindo Pharma Limited, Dr. Reddy's Laboratories, SCYNEXIS, Inc., Basilea Pharmaceutica Ltd., Astellas Pharma Inc., Grupo Ferrer Internacional, S.A., Pacgen Life Science Corporation, NovaDigm Therapeutics, Inc., Cidara Therapeutics, Inc., and Amplyx Pharmaceuticals Inc.

Chapter 21 - Assumptions and Acronyms Used

  • This chapter includes a list of acronyms and assumptions that provide a base for the information and statistics included in the report.

Chapter 22 - Research Methodology

  • This chapter helps readers understand the research methodology followed to obtain various conclusions, important qualitative information, and quantitative information about the vaginal antifungals market.

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand Side Trends
  • 1.3. Supply Side Trends
  • 1.4. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations
  • 2.3. Inclusions and Exclusions

3. Key Market Trends

  • 3.1. Key Trends Impacting the Market
  • 3.2. Key Innovation / Development Trends

4. Key Success Factors

  • 4.1. Promotional Strategies, By Key Manufacturers
  • 4.2. Key Regulations
  • 4.3. Reimbursement Scenario
  • 4.4. Pipeline Analysis
  • 4.5. Value Chain Analysis
  • 4.6. PESTEL Analysis
  • 4.7. Porter's Analysis

5. Market Background

  • 5.1. Macro-Economic Factors
    • 5.1.1. Global GDP Growth Outlook
    • 5.1.2. Global Healthcare Expenditure Outlook
    • 5.1.3. Global Antifungal Drugs Market Outlook
  • 5.2. Forecast Factors - Relevance & Impact
    • 5.2.1. Impact of the COVID-19 Pandemic
    • 5.2.2. Increasing Product Launch Activities
    • 5.2.3. Prevalence of Vaginal Fungal Infections in HRT Patients
    • 5.2.4. High Rates of Vulvovaginal Candidiasis
    • 5.2.5. Impact on Quality-of-Life
    • 5.2.6. Increasing Number of People with Predisposing Conditions Such as Diabetes Treated with SGLT2 Inhibitors
    • 5.2.7. Growing Problems of Azole Resistance
    • 5.2.8. Toxicity of Antifungal Drugs
  • 5.3. Market Dynamics
    • 5.3.1. Drivers
    • 5.3.2. Restraints
    • 5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

  • 6.1. COVID-19 and Impact Analysis
    • 6.1.1. By Drug
    • 6.1.2. By Route of Administration
    • 6.1.3. By Distribution Channel
    • 6.1.4. By Country
  • 6.2. 2021 Market Scenario

7. Global Vaginal Antifungals Market Demand (in Value or Size in US$ Mn) Analysis 2017-2021 and Forecast, 2022-2032

  • 7.1. Historical Market Value (US$ Mn) Analysis, 2017-2021
  • 7.2. Current and Future Market Value (US$ Mn) Projections, 2022-2032
    • 7.2.1. Y-o-Y Growth Trend Analysis
    • 7.2.2. Absolute $ Opportunity Analysis

8. Global Vaginal Antifungals Market Analysis 2017-2021 and Forecast 2022-2032, By Drug

  • 8.1. Introduction / Key Findings
  • 8.2. Historical Market Size (US$ Mn) Analysis By Drug, 2017 - 2021
  • 8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Drug, 2022 - 2032
    • 8.3.1. Fluconazole
    • 8.3.2. Nystatin
    • 8.3.3. Flucytosine
    • 8.3.4. Clotrimazole
    • 8.3.5. Ketoconazole
    • 8.3.6. Terbinafine
    • 8.3.7. Others
  • 8.4. Market Attractiveness Analysis By Drug

9. Global Vaginal Antifungals Market Analysis 2017-2021 and Forecast 2022-2032, By Route of Administration

  • 9.1. Introduction / Key Findings
  • 9.2. Historical Market Size (US$ Mn) Analysis By Route of Administration, 2017 - 2021
  • 9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Route of Administration, 2022 - 2032
    • 9.3.1. Oral
    • 9.3.2. Topical
  • 9.4. Market Attractiveness Analysis By Route of Administration

10. Global Vaginal Antifungals Market Analysis 2017-2021 and Forecast 2022-2032, By Distribution Channel

  • 10.1. Introduction / Key Findings
  • 10.2. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2017 - 2021
  • 10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Distribution Channel, 2022 - 2032
    • 10.3.1. Hospital Pharmacies
    • 10.3.2. Retail Pharmacies
    • 10.3.3. Online Pharmacies
  • 10.4. Market Attractiveness Analysis By Distribution Channel

11. Global Vaginal Antifungals Market Analysis 2017-2021 and Forecast 2022-2032, By Region

  • 11.1. Introduction / Key Findings
  • 11.2. Historical Market Size (US$ Mn) Analysis By Region, 2017-2021
  • 11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Region, 2022-2032
    • 11.3.1. North America
    • 11.3.2. Latin America
    • 11.3.3. Europe
    • 11.3.4. East Asia
    • 11.3.5. South Asia
    • 11.3.6. Oceania
    • 11.3.7. Middle East and Africa
  • 11.4. Market Attractiveness Analysis By Region

12. North America Vaginal Antifungals Market Analysis 2017-2021 and Forecast 2022-2032

  • 12.1. Introduction
  • 12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
  • 12.3. Current and Future Market Size (US$ Mn) Analysis & Forecast By Market Taxonomy, 2022-2032
    • 12.3.1. By Country
      • 12.3.1.1. U.S.
      • 12.3.1.2. Canada
    • 12.3.2. By Drug
    • 12.3.3. By Route of Administration
    • 12.3.4. By Distribution Channel
  • 12.4. Market Attractiveness Analysis
    • 12.4.1. By Country
    • 12.4.2. By Drug
    • 12.4.3. By Route of Administration
    • 12.4.4. By Distribution Channel
  • 12.5. Market Trends
  • 12.6. Key Market Participants - Intensity Mapping
  • 12.7. Drivers and Restraints - Impact Analysis
  • 12.8. Country Level Analysis & Forecast
    • 12.8.1. U.S. Vaginal Antifungals Market Analysis
      • 12.8.1.1. Introduction
      • 12.8.1.2. Market Analysis and Forecast By Market Taxonomy
        • 12.8.1.2.1. By Drug
        • 12.8.1.2.2. By Route of Administration
        • 12.8.1.2.3. By Distribution Channel
    • 12.8.2. Canada Vaginal Antifungals Market Analysis
      • 12.8.2.1. Introduction
      • 12.8.2.2. Market Analysis and Forecast By Market Taxonomy
        • 12.8.2.2.1. By Drug
        • 12.8.2.2.2. By Route of Administration
        • 12.8.2.2.3. By Distribution Channel

13. Latin America Vaginal Antifungals Market Analysis 2017-2021 and Forecast 2022-2032

  • 13.1. Introduction
  • 13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
  • 13.3. Current and Future Market Size (US$ Mn) Analysis & Forecast By Market Taxonomy, 2022-2032
    • 13.3.1. By Country
      • 13.3.1.1. Mexico
      • 13.3.1.2. Brazil
      • 13.3.1.3. Argentina
      • 13.3.1.4. Rest of Latin America
        • 13.3.1.4.1. By Country
        • 13.3.1.4.2. By Drug
        • 13.3.1.4.3. By Route of Administration
        • 13.3.1.4.4. By Distribution Channel
  • 13.4. Market Attractiveness Analysis
    • 13.4.1. By Country
    • 13.4.2. By Drug
    • 13.4.3. By Route of Administration
    • 13.4.4. By Distribution Channel
  • 13.5. Market Trends
  • 13.6. Key Market Participants - Intensity Mapping
  • 13.7. Drivers and Restraints - Impact Analysis
  • 13.8. Country Level Analysis & Forecast
    • 13.8.1. Mexico Vaginal Antifungals Market Analysis
      • 13.8.1.1. Introduction
      • 13.8.1.2. Market Analysis and Forecast By Market Taxonomy
        • 13.8.1.2.1. By Drug
        • 13.8.1.2.2. By Route of Administration
        • 13.8.1.2.3. By Distribution Channel
    • 13.8.2. Brazil Vaginal Antifungals Market Analysis
      • 13.8.2.1. Introduction
      • 13.8.2.2. Market Analysis and Forecast By Market Taxonomy
        • 13.8.2.2.1. By Country
        • 13.8.2.2.2. By Drug
        • 13.8.2.2.3. By Route of Administration
        • 13.8.2.2.4. By Distribution Channel
    • 13.8.3. Argentina Vaginal Antifungals Market Analysis
      • 13.8.3.1. Introduction
      • 13.8.3.2. Market Analysis and Forecast By Market Taxonomy
        • 13.8.3.2.1. By Drug
        • 13.8.3.2.2. By Route of Administration
        • 13.8.3.2.3. By Distribution Channel

14. Europe Vaginal Antifungals Market Analysis 2017-2021 and Forecast 2022-2032

  • 14.1. Introduction
  • 14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
  • 14.3. Current and Future Market Size (US$ Mn) Analysis & Forecast By Market Taxonomy, 2022-2032
    • 14.3.1. By Country
      • 14.3.1.1. Germany
      • 14.3.1.2. Italy
      • 14.3.1.3. France
      • 14.3.1.4. U.K.
      • 14.3.1.5. Spain
      • 14.3.1.6. BENELUX
      • 14.3.1.7. Russia
      • 14.3.1.8. Rest of Europe
    • 14.3.2. By Drug
    • 14.3.3. By Route of Administration
    • 14.3.4. By Distribution Channel
  • 14.4. Market Attractiveness Analysis
    • 14.4.1. By Country
    • 14.4.2. By Drug
    • 14.4.3. By Route of Administration
    • 14.4.4. By Distribution Channel
  • 14.5. Market Trends
  • 14.6. Key Market Participants - Intensity Mapping
  • 14.7. Drivers and Restraints - Impact Analysis
  • 14.8. Country Level Analysis & Forecast
    • 14.8.1. Germany Vaginal Antifungals Market Analysis
      • 14.8.1.1. Introduction
      • 14.8.1.2. Market Analysis and Forecast By Market Taxonomy
        • 14.8.1.2.1. By Drug
        • 14.8.1.2.2. By Route of Administration
        • 14.8.1.2.3. By Distribution Channel
    • 14.8.2. Italy Vaginal Antifungals Market Analysis
      • 14.8.2.1. Introduction
      • 14.8.2.2. Market Analysis and Forecast By Market Taxonomy
        • 14.8.2.2.1. By Drug
        • 14.8.2.2.2. By Route of Administration
        • 14.8.2.2.3. By Distribution Channel
    • 14.8.3. France Vaginal Antifungals Market Analysis
      • 14.8.3.1. Introduction
      • 14.8.3.2. Market Analysis and Forecast By Market Taxonomy
        • 14.8.3.2.1. By Drug
        • 14.8.3.2.2. By Route of Administration
        • 14.8.3.2.3. By Distribution Channel
    • 14.8.4. U.K. Vaginal Antifungals Market Analysis
      • 14.8.4.1. Introduction
      • 14.8.4.2. Market Analysis and Forecast By Market Taxonomy
        • 14.8.4.2.1. By Drug
        • 14.8.4.2.2. By Route of Administration
        • 14.8.4.2.3. By Distribution Channel
    • 14.8.5. Spain Vaginal Antifungals Market Analysis
      • 14.8.5.1. Introduction
      • 14.8.5.2. Market Analysis and Forecast By Market Taxonomy
        • 14.8.5.2.1. By Drug
        • 14.8.5.2.2. By Route of Administration
        • 14.8.5.2.3. By Distribution Channel
    • 14.8.6. BENELUX Vaginal Antifungals Market Analysis
      • 14.8.6.1. Introduction
      • 14.8.6.2. Market Analysis and Forecast By Market Taxonomy
        • 14.8.6.2.1. By Drug
        • 14.8.6.2.2. By Route of Administration
        • 14.8.6.2.3. By Distribution Channel
    • 14.8.7. Russia Vaginal Antifungals Market Analysis
      • 14.8.7.1. Introduction
      • 14.8.7.2. Market Analysis and Forecast By Market Taxonomy
        • 14.8.7.2.1. By Drug
        • 14.8.7.2.2. By Route of Administration
        • 14.8.7.2.3. By Distribution Channel

15. East Asia Vaginal Antifungals Market Analysis 2017-2021 and Forecast 2022-2032

  • 15.1. Introduction
  • 15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
  • 15.3. Current and Future Market Size (US$ Mn) Analysis & Forecast By Market Taxonomy, 2022-2032
    • 15.3.1. By Country
      • 15.3.1.1. China
      • 15.3.1.2. Japan
      • 15.3.1.3. South Korea
    • 15.3.2. By Drug
    • 15.3.3. By Route of Administration
    • 15.3.4. By Distribution Channel
  • 15.4. Market Attractiveness Analysis
    • 15.4.1. By Country
    • 15.4.2. By Drug
    • 15.4.3. By Route of Administration
    • 15.4.4. By Distribution Channel
  • 15.5. Market Trends
  • 15.6. Key Market Participants - Intensity Mapping
  • 15.7. Drivers and Restraints - Impact Analysis
  • 15.8. Country Level Analysis & Forecast
    • 15.8.1. China Vaginal Antifungals Market Analysis
      • 15.8.1.1. Introduction
      • 15.8.1.2. Market Analysis and Forecast By Market Taxonomy
        • 15.8.1.2.1. By Drug
        • 15.8.1.2.2. By Route of Administration
        • 15.8.1.2.3. By Distribution Channel
    • 15.8.2. Japan Vaginal Antifungals Market Analysis
      • 15.8.2.1. Introduction
      • 15.8.2.2. Market Analysis and Forecast By Market Taxonomy
        • 15.8.2.2.1. By Drug
        • 15.8.2.2.2. By Route of Administration
        • 15.8.2.2.3. By Distribution Channel
    • 15.8.3. South Korea Vaginal Antifungals Market Analysis
      • 15.8.3.1. Introduction
      • 15.8.3.2. Market Analysis and Forecast By Market Taxonomy
        • 15.8.3.2.1. By Drug
        • 15.8.3.2.2. By Route of Administration
        • 15.8.3.2.3. By Distribution Channel

16. South Asia Vaginal Antifungals Market Analysis 2017-2021 and Forecast 2022-2032

  • 16.1. Introduction
  • 16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
  • 16.3. Current and Future Market Size (US$ Mn) Analysis & Forecast By Market Taxonomy, 2022-2032
    • 16.3.1. By Country
      • 16.3.1.1. India
      • 16.3.1.2. Indonesia
      • 16.3.1.3. Malaysia
      • 16.3.1.4. Thailand
      • 16.3.1.5. Rest of South Asia
    • 16.3.2. By Drug
    • 16.3.3. By Route of Administration
    • 16.3.4. By Distribution Channel
  • 16.4. Market Attractiveness Analysis
    • 16.4.1. By Country
    • 16.4.2. By Drug
    • 16.4.3. By Route of Administration
    • 16.4.4. By Distribution Channel
  • 16.5. Market Trends
  • 16.6. Key Market Participants - Intensity Mapping
  • 16.7. Drivers and Restraints - Impact Analysis
  • 16.8. Country Level Analysis & Forecast
    • 16.8.1. India Vaginal Antifungals Market Analysis
      • 16.8.1.1. Introduction
      • 16.8.1.2. Market Analysis and Forecast By Market Taxonomy
        • 16.8.1.2.1. By Drug
        • 16.8.1.2.2. By Route of Administration
        • 16.8.1.2.3. By Distribution Channel
    • 16.8.2. Indonesia Vaginal Antifungals Market Analysis
      • 16.8.2.1. Introduction
      • 16.8.2.2. Market Analysis and Forecast By Market Taxonomy
        • 16.8.2.2.1. By Drug
        • 16.8.2.2.2. By Route of Administration
        • 16.8.2.2.3. By Distribution Channel
    • 16.8.3. Malaysia Vaginal Antifungals Market Analysis
      • 16.8.3.1. Introduction
      • 16.8.3.2. Market Analysis and Forecast By Market Taxonomy
        • 16.8.3.2.1. By Drug
        • 16.8.3.2.2. By Route of Administration
        • 16.8.3.2.3. By Distribution Channel
    • 16.8.4. Thailand Vaginal Antifungals Market Analysis
      • 16.8.4.1. Introduction
      • 16.8.4.2. Market Analysis and Forecast By Market Taxonomy
        • 16.8.4.2.1. By Drug
        • 16.8.4.2.2. By Route of Administration
        • 16.8.4.2.3. By Distribution Channel

17. Oceania Vaginal Antifungals Market 2017-2021 and Forecast 2022-2032

  • 17.1. Introduction
  • 17.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
  • 17.3. Current and Future Market Size (US$ Mn) Analysis & Forecast By Market Taxonomy, 2022-2032
    • 17.3.1. By Country
      • 17.3.1.1. Australia
      • 17.3.1.2. New Zealand
    • 17.3.2. By Drug
    • 17.3.3. By Route of Administration
    • 17.3.4. By Distribution Channel
  • 17.4. Market Attractiveness Analysis
    • 17.4.1. By Country
    • 17.4.2. By Drug
    • 17.4.3. By Route of Administration
    • 17.4.4. By Distribution Channel
  • 17.5. Key Market Participants - Intensity Mapping
  • 17.6. Drivers and Restraints - Impact Analysis
  • 17.7. Country Level Analysis & Forecast
    • 17.7.1. Australia Vaginal Antifungals Market Analysis
      • 17.7.1.1. Introduction
      • 17.7.1.2. Market Analysis and Forecast By Market Taxonomy
        • 17.7.1.2.1. By Drug
        • 17.7.1.2.2. By Route of Administration
        • 17.7.1.2.3. By Distribution Channel
    • 17.7.2. New Zealand Vaginal Antifungals Market Analysis
      • 17.7.2.1. Introduction
      • 17.7.2.2. Market Analysis and Forecast By Market Taxonomy
        • 17.7.2.2.1. By Drug
        • 17.7.2.2.2. By Route of Administration
        • 17.7.2.2.3. By Distribution Channel

18. Middle East and Africa (MEA) Vaginal Antifungals Market Analysis 2017-2021 and Forecast 2022-2032

  • 18.1. Introduction
  • 18.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
  • 18.3. Current and Future Market Size (US$ Mn) Analysis & Forecast By Market Taxonomy, 2022-2032
    • 18.3.1. By Country
      • 18.3.1.1. GCC Countries
      • 18.3.1.2. Turkiye
      • 18.3.1.3. South Africa
      • 18.3.1.4. North Africa
      • 18.3.1.5. Rest of Middle East and Africa
    • 18.3.2. By Drug
    • 18.3.3. By Route of Administration
    • 18.3.4. By Distribution Channel
  • 18.4. Market Attractiveness Analysis
    • 18.4.1. By Country
    • 18.4.2. By Drug
    • 18.4.3. By Route of Administration
    • 18.4.4. By Distribution Channel
  • 18.5. Market Trends
  • 18.6. Key Market Participants - Intensity Mapping
  • 18.7. Drivers and Restraints - Impact Analysis
  • 18.8. Country Level Analysis & Forecast
    • 18.8.1. GCC Countries Vaginal Antifungals Market Analysis
      • 18.8.1.1. Introduction
      • 18.8.1.2. Market Analysis and Forecast By Market Taxonomy
        • 18.8.1.2.1. By Drug
        • 18.8.1.2.2. By Route of Administration
        • 18.8.1.2.3. By Distribution Channel
    • 18.8.2. Turkiye Vaginal Antifungals Market Analysis
      • 18.8.2.1. Introduction
      • 18.8.2.2. Market Analysis and Forecast By Market Taxonomy
        • 18.8.2.2.1. By Drug
        • 18.8.2.2.2. By Route of Administration
        • 18.8.2.2.3. By Distribution Channel
    • 18.8.3. South Africa Vaginal Antifungals Market Analysis
      • 18.8.3.1. Introduction
      • 18.8.3.2. Market Analysis and Forecast By Market Taxonomy
        • 18.8.3.2.1. By Drug
        • 18.8.3.2.2. By Route of Administration
        • 18.8.3.2.3. By Distribution Channel
    • 18.8.4. North Africa Vaginal Antifungals Market Analysis
      • 18.8.4.1. Introduction
      • 18.8.4.2. Market Analysis and Forecast By Market Taxonomy
        • 18.8.4.2.1. By Drug
        • 18.8.4.2.2. By Route of Administration
        • 18.8.4.2.3. By Distribution Channel

19. Market Structure Analysis

  • 19.1. Market Analysis By Tier of Companies
  • 19.2. Market Concentration
  • 19.3. Market Share Analysis of Top Players
  • 19.4. Market Presence Analysis

20. Competition Analysis

  • 20.1. Competition Dashboard
  • 20.2. Competition Benchmarking
  • 20.3. Competition Deep Dive
    • 20.3.1. Pfizer Inc.
      • 20.3.1.1. Overview
      • 20.3.1.2. Product Portfolio
      • 20.3.1.3. Sales Footprint
      • 20.3.1.4. Key Financials
      • 20.3.1.5. SWOT Analysis
      • 20.3.1.6. Strategic Overview
    • 20.3.2. Bausch Health Companies Inc
      • 20.3.2.1. Overview
      • 20.3.2.2. Product Portfolio
      • 20.3.2.3. Sales Footprint
      • 20.3.2.4. Key Financials
      • 20.3.2.5. SWOT Analysis
      • 20.3.2.6. Strategic Overview
    • 20.3.3. ANI Pharmaceuticals, Inc.
      • 20.3.3.1. Overview
      • 20.3.3.2. Product Portfolio
      • 20.3.3.3. Sales Footprint
      • 20.3.3.4. Key Financials
      • 20.3.3.5. SWOT Analysis
      • 20.3.3.6. Strategic Overview
    • 20.3.4. Hikma Pharmaceuticals Plc
      • 20.3.4.1. Overview
      • 20.3.4.2. Product Portfolio
      • 20.3.4.3. Sales Footprint
      • 20.3.4.4. Key Financials
      • 20.3.4.5. SWOT Analysis
      • 20.3.4.6. Strategic Overview
    • 20.3.5. Lupin Limited
      • 20.3.5.1. Overview
      • 20.3.5.2. Product Portfolio
      • 20.3.5.3. Sales Footprint
      • 20.3.5.4. Key Financials
      • 20.3.5.5. SWOT Analysis
      • 20.3.5.6. Strategic Overview
    • 20.3.6. Mycovia Pharmaceuticals, Inc.
      • 20.3.6.1. Overview
      • 20.3.6.2. Product Portfolio
      • 20.3.6.3. Sales Footprint
      • 20.3.6.4. Key Financials
      • 20.3.6.5. SWOT Analysis
      • 20.3.6.6. Strategic Overview
    • 20.3.7. Glenmark Pharmaceuticals Limited
      • 20.3.7.1. Overview
      • 20.3.7.2. Product Portfolio
      • 20.3.7.3. Sales Footprint
      • 20.3.7.4. Key Financials
      • 20.3.7.5. SWOT Analysis
      • 20.3.7.6. Strategic Overview
    • 20.3.8. Unique Pharmaceuticals
      • 20.3.8.1. Overview
      • 20.3.8.2. Product Portfolio
      • 20.3.8.3. Sales Footprint
      • 20.3.8.4. Key Financials
      • 20.3.8.5. SWOT Analysis
      • 20.3.8.6. Strategic Overview
    • 20.3.9. PEPTONIC medical AB
      • 20.3.9.1. Overview
      • 20.3.9.2. Product Portfolio
      • 20.3.9.3. Sales Footprint
      • 20.3.9.4. Key Financials
      • 20.3.9.5. SWOT Analysis
      • 20.3.9.6. Strategic Overview
    • 20.3.10. Aurobindo Pharma Limited
      • 20.3.10.1. Overview
      • 20.3.10.2. Product Portfolio
      • 20.3.10.3. Sales Footprint
      • 20.3.10.4. Key Financials
      • 20.3.10.5. SWOT Analysis
      • 20.3.10.6. Strategic Overview
    • 20.3.11. Dr. Reddy's Laboratories
      • 20.3.11.1. Overview
      • 20.3.11.2. Product Portfolio
      • 20.3.11.3. Sales Footprint
      • 20.3.11.4. Key Financials
      • 20.3.11.5. SWOT Analysis
      • 20.3.11.6. Strategic Overview
    • 20.3.12. SCYNEXIS, Inc.
      • 20.3.12.1. Overview
      • 20.3.12.2. Product Portfolio
      • 20.3.12.3. Sales Footprint
      • 20.3.12.4. Key Financials
      • 20.3.12.5. SWOT Analysis
      • 20.3.12.6. Strategic Overview
    • 20.3.13. Basilea Pharmaceutica Ltd.
      • 20.3.13.1. Overview
      • 20.3.13.2. Product Portfolio
      • 20.3.13.3. Sales Footprint
      • 20.3.13.4. Key Financials
      • 20.3.13.5. SWOT Analysis
      • 20.3.13.6. Strategic Overview
    • 20.3.14. Astellas Pharma Inc.
      • 20.3.14.1. Overview
      • 20.3.14.2. Product Portfolio
      • 20.3.14.3. Sales Footprint
      • 20.3.14.4. Key Financials
      • 20.3.14.5. SWOT Analysis
      • 20.3.14.6. Strategic Overview
    • 20.3.15. Grupo Ferrer Internacional, S.A.
      • 20.3.15.1. Overview
      • 20.3.15.2. Product Portfolio
      • 20.3.15.3. Sales Footprint
      • 20.3.15.4. Key Financials
      • 20.3.15.5. SWOT Analysis
      • 20.3.15.6. Strategic Overview
    • 20.3.16. Pacgen Life Science Corporation
      • 20.3.16.1. Overview
      • 20.3.16.2. Product Portfolio
      • 20.3.16.3. Sales Footprint
      • 20.3.16.4. Key Financials
      • 20.3.16.5. SWOT Analysis
      • 20.3.16.6. Strategic Overview
    • 20.3.17. NovaDigm Therapeutics, Inc.
      • 20.3.17.1. Overview
      • 20.3.17.2. Product Portfolio
      • 20.3.17.3. Sales Footprint
      • 20.3.17.4. Key Financials
      • 20.3.17.5. SWOT Analysis
      • 20.3.17.6. Strategic Overview
    • 20.3.18. Cidara Therapeutics, Inc.
      • 20.3.18.1. Overview
      • 20.3.18.2. Product Portfolio
      • 20.3.18.3. Sales Footprint
      • 20.3.18.4. Key Financials
      • 20.3.18.5. SWOT Analysis
      • 20.3.18.6. Strategic Overview
    • 20.3.19. Amplyx Pharmaceuticals Inc.
      • 20.3.19.1. Overview
      • 20.3.19.2. Product Portfolio
      • 20.3.19.3. Sales Footprint
      • 20.3.19.4. Key Financials
      • 20.3.19.5. SWOT Analysis
      • 20.3.19.6. Strategic Overview

21. Assumptions and Acronyms Used

22. Research Methodology

List of Tables

  • Table 01: Global Vaginal Antifungals Market Analysis 2012-2021 and Forecast 2022-2032, by Drug
  • Table 02: Global Vaginal Antifungals Market Analysis 2012-2021 and Forecast 2022-2032by Route of Administration
  • Table 03: Global Vaginal Antifungals Market Analysis 2012-2021 and Forecast 2022-2032, by Distribution Channel
  • Table 04: Global Vaginal Antifungals Market Analysis 2012-2021 and Forecast 2022-2032, by Region
  • Table 05: North America Vaginal Antifungals Market Value (US$ Mn) Analysis 2012-2021 and Forecast 2022-2032, by Country
  • Table 06: North America Vaginal Antifungals Market Value (US$ Mn) Analysis 2012-2021 and Forecast 2022-2032, by Drug
  • Table 07: North America Vaginal Antifungals Market Value (US$ Mn) Analysis 2012-2021 and Forecast 2022-2032, by Route of Administration
  • Table 08: North America Vaginal Antifungals Market Value (US$ Mn) Analysis 2012-2021 and Forecast 2022-2032, by Distribution Channel
  • Table 09: Latin America Vaginal Antifungals Market Value (US$ Mn) Analysis 2012-2021 and Forecast 2022-2032, by Country
  • Table 10: Latin America Vaginal Antifungals Market Value (US$ Mn) Analysis 2012-2021 and Forecast 2022-2032, by Drug
  • Table 11: Latin America Vaginal Antifungals Market Value (US$ Mn) Analysis 2012-2021 and Forecast 2022-2032, by Route of Administration
  • Table 12: Latin America Vaginal Antifungals Market Value (US$ Mn) Analysis 2012-2021 and Forecast 2022-2032, by Distribution Channel
  • Table 13: Europe Vaginal Antifungals Market Value (US$ Mn) Analysis 2012-2021 and Forecast 2022-2032, by Country
  • Table 14: Europe Vaginal Antifungals Market Value (US$ Mn) Analysis 2012-2021 and Forecast 2022-2032, by Drug
  • Table 15: Europe Vaginal Antifungals Market Analysis 2012-2021 and Forecast 2022-2032by Route of Administration
  • Table 16: Europe Vaginal Antifungals Market Value (US$ Mn) Analysis 2012-2021 and Forecast 2022-2032, by Distribution Channel
  • Table 17: East Asia Vaginal Antifungals Market Value (US$ Mn) Analysis 2012-2021 and Forecast 2022-2032, by Country
  • Table 18: East Asia Vaginal Antifungals Market Value (US$ Mn) Analysis 2012-2021 and Forecast 2022-2032, by Drug
  • Table 19: East Asia Vaginal Antifungals Market Value (US$ Mn) Analysis 2012-2021 and Forecast 2022-2032, by Route of Administration
  • Table 20: East Asia Vaginal Antifungals Market Value (US$ Mn) Analysis 2012-2021 and Forecast 2022-2032, by Distribution Channel
  • Table 21: South Asia Vaginal Antifungals Market Value (US$ Mn) Analysis 2012-2021 and Forecast 2022-2032, by Country
  • Table 22: South Asia Vaginal Antifungals Market Value (US$ Mn) Analysis 2012-2021 and Forecast 2022-2032, by Drug
  • Table 23: South Asia Vaginal Antifungals Market Value (US$ Mn) Analysis 2012-2021 and Forecast 2022-2032, by Route of Administration
  • Table 24: South Asia Vaginal Antifungals Market Value (US$ Mn) Analysis 2012-2021 and Forecast 2022-2032, by Distribution Channel
  • Table 25: Oceania Vaginal Antifungals Market Value (US$ Mn) Analysis 2012-2021 and Forecast 2022-2032, by Country
  • Table 26: Oceania Vaginal Antifungals Market Value (US$ Mn) Analysis 2012-2021 and Forecast 2022-2032, by Drug
  • Table 27: Oceania Vaginal Antifungals Market Analysis 2012-2021 and Forecast 2022-2032by Route of Administration
  • Table 28: Oceania Vaginal Antifungals Market Value (US$ Mn) Analysis 2012-2021 and Forecast 2022-2032, by Distribution Channel
  • Table 29: Middle East & Africa Vaginal Antifungals Market Value (US$ Mn) Analysis 2012-2021 and Forecast 2022-2032, by Country
  • Table 30: Middle East & Africa Vaginal Antifungals Market Value (US$ Mn) Analysis 2012-2021 and Forecast 2022-2032, by Drug
  • Table 31: Middle East & Africa Vaginal Antifungals Market Analysis 2012-2021 and Forecast 2022-2032by Route of Administration
  • Table 32: Middle East & Africa Vaginal Antifungals Market Value (US$ Mn) Analysis 2012-2021 and Forecast 2022-2032, by Distribution Channel

List of Figures

  • Figure 01: Global Vaginal Antifungals Market Value (US$ Mn) Analysis, 2012-2021
  • Figure 02: Global Vaginal Antifungals Market Forecast & Y-o-Y Growth, 2022-2032
  • Figure 03: Global Vaginal Antifungals Market Absolute $ Opportunity (US$ Mn) Analysis, 2021-2032
  • Figure 04: Global Vaginal Antifungals Market Value Share (%) Analysis 2022 and 2032, by Drug
  • Figure 05: Global Vaginal Antifungals Market Y-o-Y Growth (%) Analysis 2021-2032, by Drug
  • Figure 06: Global Vaginal Antifungals Market Attractiveness Analysis 2022-2032, by Drug
  • Figure 07: Global Vaginal Antifungals Market Value Share (%) Analysis 2022 and 2032, by Route of Administration
  • Figure 08: Global Vaginal Antifungals Market Y-o-Y Growth (%) Analysis 2021-2032, by Route of Administration
  • Figure 09: Global Vaginal Antifungals Market Attractiveness Analysis 2022-2032, by Route of Administration
  • Figure 10: Global Vaginal Antifungals Market Value Share (%) Analysis 2022 and 2032, by Distribution Channel
  • Figure 11: Global Vaginal Antifungals Market Y-o-Y Growth (%) Analysis 2021-2032, by Distribution Channel
  • Figure 12: Global Vaginal Antifungals Market Attractiveness Analysis 2022-2032, by Distribution Channel
  • Figure 13: Global Vaginal Antifungals Market Value Share (%) Analysis 2022 and 2032, by Region
  • Figure 14: Global Vaginal Antifungals Market Y-o-Y Growth (%) Analysis 2021-2032, by Region
  • Figure 15: Global Vaginal Antifungals Market Attractiveness Analysis 2022-2032, by Region
  • Figure 16: North America Vaginal Antifungals Market Value (US$ Mn) Analysis, 2012-2021
  • Figure 17: North America Vaginal Antifungals Market Value (US$ Mn) Forecast, 2022-2032
  • Figure 18: North America Vaginal Antifungals Market Value Share, by Drug (2022 E)
  • Figure 19: North America Vaginal Antifungals Market Value Share, by Route of Administration (2022 E)
  • Figure 20: North America Vaginal Antifungals Market Value Share, by Distribution Channel (2022 E)
  • Figure 21: North America Vaginal Antifungals Market Value Share, by Country (2022 E)
  • Figure 22: North America Vaginal Antifungals Market Attractiveness Analysis by Drug, 2022-2032
  • Figure 23: North America Vaginal Antifungals Market Attractiveness Analysis by Route of Administration, 2022-2032
  • Figure 24: North America Vaginal Antifungals Market Attractiveness Analysis by Distribution Channel, 2022-2032
  • Figure 25: North America Vaginal Antifungals Market Attractiveness Analysis by Country, 2022-2032
  • Figure 26: U.S. Vaginal Antifungals Market Value Proportion Analysis, 2021
  • Figure 27: Global Vs. U.S. Growth Comparison
  • Figure 28: U.S. Vaginal Antifungals Market Share Analysis (%) by Drug, 2021 & 2032
  • Figure 29: U.S. Vaginal Antifungals Market Share Analysis (%) by Route of Administration, 2021 & 2032
  • Figure 30: U.S. Vaginal Antifungals Market Share Analysis (%) by Distribution Channel, 2021 & 2032
  • Figure 31: Canada Vaginal Antifungals Market Value Proportion Analysis, 2021
  • Figure 32: Global Vs. Canada. Growth Comparison
  • Figure 33: Canada Vaginal Antifungals Market Share Analysis (%) by Drug, 2021 & 2032
  • Figure 34: Canada Vaginal Antifungals Market Share Analysis (%) by Route of Administration, 2021 & 2032
  • Figure 35: Canada Vaginal Antifungals Market Share Analysis (%) by Distribution Channel, 2021 & 2032
  • Figure 36: Latin America Vaginal Antifungals Market Value (US$ Mn) Analysis, 2012-2021
  • Figure 37: Latin America Vaginal Antifungals Market Value (US$ Mn) Forecast, 2022-2032
  • Figure 38: Latin America Vaginal Antifungals Market Value Share, by Drug (2022 E)
  • Figure 39: Latin America Vaginal Antifungals Market Value Share, by Route of Administration (2022 E)
  • Figure 40: Latin America Vaginal Antifungals Market Value Share, by Distribution Channel (2022 E)
  • Figure 41: Latin America Vaginal Antifungals Market Value Share, by Country (2022 E)
  • Figure 42: Latin America Vaginal Antifungals Market Attractiveness Analysis by Drug, 2022-2032
  • Figure 43: Latin America Vaginal Antifungals Market Attractiveness Analysis by Route of Administration, 2022-2032
  • Figure 44: Latin America Vaginal Antifungals Market Attractiveness Analysis by Distribution Channel, 2022-2032
  • Figure 45: Latin America Vaginal Antifungals Market Attractiveness Analysis by Country, 2022-2032
  • Figure 46: Mexico Vaginal Antifungals Market Value Proportion Analysis, 2021
  • Figure 47: Global Vs Mexico Growth Comparison
  • Figure 48: Mexico Vaginal Antifungals Market Share Analysis (%) by Drug, 2021 & 2032
  • Figure 49: Mexico Vaginal Antifungals Market Share Analysis (%) by Route of Administration, 2021 & 2032
  • Figure 50: Mexico Vaginal Antifungals Market Share Analysis (%) by Distribution Channel, 2021 & 2032
  • Figure 51: Brazil Vaginal Antifungals Market Value Proportion Analysis, 2021
  • Figure 52: Global Vs. Brazil. Growth Comparison
  • Figure 53: Brazil Vaginal Antifungals Market Share Analysis (%) by Drug, 2021 & 2032
  • Figure 54: Brazil Vaginal Antifungals Market Share Analysis (%) by Route of Administration, 2021 & 2032
  • Figure 55: Brazil Vaginal Antifungals Market Share Analysis (%) by Distribution Channel, 2021 & 2032
  • Figure 56: Argentina Vaginal Antifungals Market Value Proportion Analysis, 2021
  • Figure 57: Global Vs Argentina Growth Comparison
  • Figure 58: Argentina Vaginal Antifungals Market Share Analysis (%) by Drug, 2021 & 2032
  • Figure 59: Argentina Vaginal Antifungals Market Share Analysis (%) by Route of Administration, 2021 & 2032
  • Figure 60: Argentina Vaginal Antifungals Market Share Analysis (%) by Distribution Channel, 2021 & 2032
  • Figure 61: Europe Vaginal Antifungals Market Value (US$ Mn) Analysis, 2012-2021
  • Figure 62: Europe Vaginal Antifungals Market Value (US$ Mn) Forecast, 2022-2032
  • Figure 63: Europe Vaginal Antifungals Market Value Share, by Drug (2022 E)
  • Figure 64: Europe Vaginal Antifungals Market Value Share, by Route of Administration (2022 E)
  • Figure 65: Europe Vaginal Antifungals Market Value Share, by Distribution Channel (2022 E)
  • Figure 66: Europe Vaginal Antifungals Market Value Share, by Country (2022 E)
  • Figure 67: Europe Vaginal Antifungals Market Attractiveness Analysis by Drug, 2022-2032
  • Figure 68: Europe Vaginal Antifungals Market Attractiveness Analysis by Route of Administration, 2022-2032
  • Figure 69: Europe Vaginal Antifungals Market Attractiveness Analysis by Distribution Channel, 2022-2032
  • Figure 70: Europe Vaginal Antifungals Market Attractiveness Analysis by Country, 2022-2032
  • Figure 71: UK Vaginal Antifungals Market Value Proportion Analysis, 2021
  • Figure 72: Global Vs. UK Growth Comparison
  • Figure 73: UK Vaginal Antifungals Market Share Analysis (%) by Drug, 2021 & 2032
  • Figure 74: UK Vaginal Antifungals Market Share Analysis (%) by Route of Administration, 2021 & 2032
  • Figure 75: UK Vaginal Antifungals Market Share Analysis (%) by Distribution Channel, 2021 & 2032
  • Figure 76: Germany Vaginal Antifungals Market Value Proportion Analysis, 2021
  • Figure 77: Global Vs. Germany Growth Comparison
  • Figure 78: Germany Vaginal Antifungals Market Share Analysis (%) by Drug, 2021 & 2032
  • Figure 79: Germany Vaginal Antifungals Market Share Analysis (%) by Route of Administration, 2021 & 2032
  • Figure 80: Germany Vaginal Antifungals Market Share Analysis (%) by Distribution Channel, 2021 & 2032
  • Figure 81: Italy Vaginal Antifungals Market Value Proportion Analysis, 2021
  • Figure 82: Global Vs. Italy Growth Comparison
  • Figure 83: Italy Vaginal Antifungals Market Share Analysis (%) by Drug, 2021 & 2032
  • Figure 84: Italy Vaginal Antifungals Market Share Analysis (%) by Route of Administration, 2021 & 2032
  • Figure 85: Italy Vaginal Antifungals Market Share Analysis (%) by Distribution Channel, 2021 & 2032
  • Figure 86: France Vaginal Antifungals Market Value Proportion Analysis, 2021
  • Figure 87: Global Vs France Growth Comparison
  • Figure 88: France Vaginal Antifungals Market Share Analysis (%) by Drug, 2021 & 2032
  • Figure 89: France Vaginal Antifungals Market Share Analysis (%) by Route of Administration, 2021 & 2032
  • Figure 90: France Vaginal Antifungals Market Share Analysis (%) by Distribution Channel, 2021 & 2032
  • Figure 91: Spain Vaginal Antifungals Market Value Proportion Analysis, 2021
  • Figure 92: Global Vs Spain Growth Comparison
  • Figure 93: Spain Vaginal Antifungals Market Share Analysis (%) by Drug, 2021 & 2032
  • Figure 94: Spain Vaginal Antifungals Market Share Analysis (%) by Route of Administration, 2021 & 2032
  • Figure 95: Spain Vaginal Antifungals Market Share Analysis (%) by Distribution Channel, 2021 & 2032
  • Figure 96: Russia Vaginal Antifungals Market Value Proportion Analysis, 2021
  • Figure 97: Global Vs Russia Growth Comparison
  • Figure 98: Russia Vaginal Antifungals Market Share Analysis (%) by Drug, 2021 & 2032
  • Figure 99: Russia Vaginal Antifungals Market Share Analysis (%) by Route of Administration, 2021 & 2032
  • Figure 100: Russia Vaginal Antifungals Market Share Analysis (%) by Distribution Channel, 2021 & 2032
  • Figure 101: BENELUX Vaginal Antifungals Market Value Proportion Analysis, 2021
  • Figure 102: Global Vs BENELUX Growth Comparison
  • Figure 103: BENELUX Vaginal Antifungals Market Share Analysis (%) by Drug, 2021 & 2032
  • Figure 104: BENELUX Vaginal Antifungals Market Share Analysis (%) by Route of Administration, 2021 & 2032
  • Figure 105: BENELUX Vaginal Antifungals Market Share Analysis (%) by Distribution Channel, 2021 & 2032
  • Figure 106: East Asia Vaginal Antifungals Market Value (US$ Mn) Analysis, 2012-2021
  • Figure 107: East Asia Vaginal Antifungals Market Value (US$ Mn) Forecast, 2022-2032
  • Figure 108: East Asia Vaginal Antifungals Market Value Share, by Drug (2022 E)
  • Figure 109: East Asia Vaginal Antifungals Market Value Share, by Route of Administration (2022 E)
  • Figure 110: East Asia Vaginal Antifungals Market Value Share, by Distribution Channel (2022 E)
  • Figure 111: East Asia Vaginal Antifungals Market Value Share, by Country (2022 E)
  • Figure 112: East Asia Vaginal Antifungals Market Attractiveness Analysis by Drug, 2022-2032
  • Figure 113: East Asia Vaginal Antifungals Market Attractiveness Analysis by Route of Administration, 2022-2032
  • Figure 114: East Asia Vaginal Antifungals Market Attractiveness Analysis by Distribution Channel, 2022-2032
  • Figure 115: East Asia Vaginal Antifungals Market Attractiveness Analysis by Country, 2022-2032
  • Figure 116: China Vaginal Antifungals Market Value Proportion Analysis, 2021
  • Figure 117: Global Vs. China Growth Comparison
  • Figure 118: China Vaginal Antifungals Market Share Analysis (%) by Drug, 2021 & 2032
  • Figure 119: China Vaginal Antifungals Market Share Analysis (%) by Route of Administration, 2021 & 2032
  • Figure 120: China Vaginal Antifungals Market Share Analysis (%) by Distribution Channel, 2021 & 2032
  • Figure 121: Japan Vaginal Antifungals Market Value Proportion Analysis, 2021
  • Figure 122: Global Vs. Japan Growth Comparison
  • Figure 123: Japan Vaginal Antifungals Market Share Analysis (%) by Drug, 2021 & 2032
  • Figure 124: Japan Vaginal Antifungals Market Share Analysis (%) by Route of Administration, 2021 & 2032
  • Figure 125: Japan Vaginal Antifungals Market Share Analysis (%) by Distribution Channel, 2021 & 2032
  • Figure 126: South Korea Vaginal Antifungals Market Value Proportion Analysis, 2021
  • Figure 127: Global Vs South Korea Growth Comparison
  • Figure 128: South Korea Vaginal Antifungals Market Share Analysis (%) by Drug, 2021 & 2032
  • Figure 129: South Korea Vaginal Antifungals Market Share Analysis (%) by Route of Administration, 2021 & 2032
  • Figure 130: South Korea Vaginal Antifungals Market Share Analysis (%) by Distribution Channel, 2021 & 2032
  • Figure 131: South Asia Vaginal Antifungals Market Value (US$ Mn) Analysis, 2012-2021
  • Figure 132: South Asia Vaginal Antifungals Market Value (US$ Mn) Forecast, 2022-2032
  • Figure 133: South Asia Vaginal Antifungals Market Value Share, by Drug (2022 E)
  • Figure 134: South Asia Vaginal Antifungals Market Value Share, by Route of Administration (2022 E)
  • Figure 135: South Asia Vaginal Antifungals Market Value Share, by Distribution Channel (2022 E)
  • Figure 136: South Asia Vaginal Antifungals Market Value Share, by Country (2022 E)
  • Figure 137: South Asia Vaginal Antifungals Market Attractiveness Analysis by Drug, 2022-2032
  • Figure 138: South Asia Vaginal Antifungals Market Attractiveness Analysis by Route of Administration, 2022-2032
  • Figure 139: South Asia Vaginal Antifungals Market Attractiveness Analysis by Distribution Channel, 2022-2032
  • Figure 140: South Asia Vaginal Antifungals Market Attractiveness Analysis by Country, 2022-2032
  • Figure 141: India Vaginal Antifungals Market Value Proportion Analysis, 2021
  • Figure 142: Global Vs. India Growth Comparison
  • Figure 143: India Vaginal Antifungals Market Share Analysis (%) by Drug, 2021 & 2032
  • Figure 144: India Vaginal Antifungals Market Share Analysis (%) by Route of Administration, 2021 & 2032
  • Figure 145: India Vaginal Antifungals Market Share Analysis (%) by Distribution Channel, 2021 & 2032
  • Figure 146: Indonesia Vaginal Antifungals Market Value Proportion Analysis, 2021
  • Figure 147: Global Vs. Indonesia Growth Comparison
  • Figure 148: Indonesia Vaginal Antifungals Market Share Analysis (%) by Drug, 2021 & 2032
  • Figure 149: Indonesia Vaginal Antifungals Market Share Analysis (%) by Route of Administration, 2021 & 2032
  • Figure 150: Indonesia Vaginal Antifungals Market Share Analysis (%) by Distribution Channel, 2021 & 2032
  • Figure 151: Malaysia Vaginal Antifungals Market Value Proportion Analysis, 2021
  • Figure 152: Global Vs. Malaysia Growth Comparison
  • Figure 153: Malaysia Vaginal Antifungals Market Share Analysis (%) by Drug, 2021 & 2032
  • Figure 154: Malaysia Vaginal Antifungals Market Share Analysis (%) by Route of Administration, 2021 & 2032
  • Figure 155: Malaysia Vaginal Antifungals Market Share Analysis (%) by Distribution Channel, 2021 & 2032
  • Figure 156: Thailand Vaginal Antifungals Market Value Proportion Analysis, 2021
  • Figure 157: Global Vs. Thailand Growth Comparison
  • Figure 158: Thailand Vaginal Antifungals Market Share Analysis (%) by Drug, 2021 & 2032
  • Figure 159: Thailand Vaginal Antifungals Market Share Analysis (%) by Route of Administration, 2021 & 2032
  • Figure 160: Thailand Vaginal Antifungals Market Share Analysis (%) by Distribution Channel, 2021 & 2032
  • Figure 161: Oceania Vaginal Antifungals Market Value (US$ Mn) Analysis, 2012-2021
  • Figure 162: Oceania Vaginal Antifungals Market Value (US$ Mn) Forecast, 2022-2032
  • Figure 163: Oceania Vaginal Antifungals Market Value Share, by Drug (2022 E)
  • Figure 164: Oceania Vaginal Antifungals Market Value Share, by Route of Administration (2022 E)
  • Figure 165: Oceania Vaginal Antifungals Market Value Share, by Distribution Channel (2022 E)
  • Figure 166: Oceania Vaginal Antifungals Market Value Share, by Country (2022 E)
  • Figure 167: Oceania Vaginal Antifungals Market Attractiveness Analysis by Drug, 2022-2032
  • Figure 168: Oceania Vaginal Antifungals Market Attractiveness Analysis by Route of Administration, 2022-2032
  • Figure 169: Oceania Vaginal Antifungals Market Attractiveness Analysis by Distribution Channel, 2022-2032
  • Figure 170: Oceania Vaginal Antifungals Market Attractiveness Analysis by Country, 2022-2032
  • Figure 171: Australia Vaginal Antifungals Market Value Proportion Analysis, 2021
  • Figure 172: Global Vs. Australia Growth Comparison
  • Figure 173: Australia Vaginal Antifungals Market Share Analysis (%) by Drug, 2021 & 2032
  • Figure 174: Australia Vaginal Antifungals Market Share Analysis (%) by Route of Administration, 2021 & 2032
  • Figure 175: Australia Vaginal Antifungals Market Share Analysis (%) by Distribution Channel, 2021 & 2032
  • Figure 176: New Zealand Vaginal Antifungals Market Value Proportion Analysis, 2021
  • Figure 177: Global Vs New Zealand Growth Comparison
  • Figure 178: New Zealand Vaginal Antifungals Market Share Analysis (%) by Drug, 2021 & 2032
  • Figure 179: New Zealand Vaginal Antifungals Market Share Analysis (%) by Route of Administration, 2021 & 2032
  • Figure 180: New Zealand Vaginal Antifungals Market Share Analysis (%) by Distribution Channel, 2021 & 2032
  • Figure 181: Middle East & Africa Vaginal Antifungals Market Value (US$ Mn) Analysis, 2012-2021
  • Figure 182: Middle East & Africa Vaginal Antifungals Market Value (US$ Mn) Forecast, 2022-2032
  • Figure 183: Middle East & Africa Vaginal Antifungals Market Value Share, by Drug (2022 E)
  • Figure 184: Middle East & Africa Vaginal Antifungals Market Value Share, by Route of Administration (2022 E)
  • Figure 185: Middle East & Africa Vaginal Antifungals Market Value Share, by Distribution Channel (2022 E)
  • Figure 186: Middle East & Africa Vaginal Antifungals Market Value Share, by Country (2022 E)
  • Figure 187: Middle East & Africa Vaginal Antifungals Market Attractiveness Analysis by Drug, 2022-2032
  • Figure 188: Middle East & Africa Vaginal Antifungals Market Attractiveness Analysis by Route of Administration, 2022-2032
  • Figure 189: Middle East & Africa Vaginal Antifungals Market Attractiveness Analysis by Distribution Channel, 2022-2032
  • Figure 190: Middle East & Africa Vaginal Antifungals Market Attractiveness Analysis by Country, 2022-2032
  • Figure 191: GCC Countries Vaginal Antifungals Market Value Proportion Analysis, 2021
  • Figure 192: Global Vs GCC Countries Growth Comparison
  • Figure 193: GCC Countries Vaginal Antifungals Market Share Analysis (%) by Drug, 2021 & 2032
  • Figure 194: GCC Countries Vaginal Antifungals Market Share Analysis (%) by Route of Administration, 2021 & 2032
  • Figure 195: GCC Countries Vaginal Antifungals Market Share Analysis (%) by Distribution Channel, 2021 & 2032
  • Figure 196: Turkiye Vaginal Antifungals Market Value Proportion Analysis, 2021
  • Figure 197: Global Vs. Turkiye Growth Comparison
  • Figure 198: Turkiye Vaginal Antifungals Market Share Analysis (%) by Drug, 2021 & 2032
  • Figure 199: Turkiye Vaginal Antifungals Market Share Analysis (%) by Route of Administration, 2021 & 2032
  • Figure 200: Turkiye Vaginal Antifungals Market Share Analysis (%) by Distribution Channel, 2021 & 2032
  • Figure 201: South Africa Vaginal Antifungals Market Value Proportion Analysis, 2021
  • Figure 202: Global Vs. South Africa Growth Comparison
  • Figure 203: South Africa Vaginal Antifungals Market Share Analysis (%) by Drug, 2021 & 2032
  • Figure 204: South Africa Vaginal Antifungals Market Share Analysis (%) by Route of Administration, 2021 & 2032
  • Figure 205: South Africa Vaginal Antifungals Market Share Analysis (%) by Distribution Channel, 2021 & 2032
  • Figure 206: North Africa Vaginal Antifungals Market Value Proportion Analysis, 2021
  • Figure 207: Global Vs North Africa Growth Comparison
  • Figure 208: North Africa Vaginal Antifungals Market Share Analysis (%) by Drug, 2021 & 2032
  • Figure 209: North Africa Vaginal Antifungals Market Share Analysis (%) by Route of Administration, 2021 & 2032
  • Figure 210: North Africa Vaginal Antifungals Market Share Analysis (%) by Distribution Channel, 2021 & 2032